ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN THE THERAPEUTIC CLINIC

Authors

  • М.S. Maltseva
  • L.O. Martymianova
  • О.O. Vlasenko
  • V.M. Savchenko

Keywords:

clinical pharmacology, inhibitors of angiotensin converting enzyme

Abstract

The clinical pharmacology of inhibitors of angiotensin converting enzyme (IACE) in the classification system of ATS is described. Clinical classification, pharmacokinetics and peculiarities of drugs of this group are submitted. Indications for use and features of use of ACE inhibitors in a therapeutic clinic are considered. The emphases of this group of drugs are placed for hypertension, heart failure and ischemic heart disease. The primary contraindications, emphases of interaction with other drugs, side effects and symptoms of overdose are given.

Downloads

Issue

No. 18 (2009)

Section

Clinical research

License

The Journal of V. N. Karazin Kharkiv National University, series Medicine has following copyright terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work, with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.

How to Cite

ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN THE THERAPEUTIC CLINIC. (2015). The Journal of V. N. Karazin Kharkiv National University, Series "Medicine", 18, 31-39. https://periodicals.karazin.ua/medicine/article/view/6954